iNtRON Biotechnology, Inc. (048530.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap110.99B
Enterprise Value86.72B
P/E Ratio-8.9
PEG Ratio0.15
Price/Sales Ratio12.45
Price/Book Ratio1.47
Enterprise/Revenue9.52
Enterprise/EBITDA-7.94

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-1.47
Operating Margin-1.09
AD

Management Effectiveness

Return On Assets-0.16
Return On Equity-0.16

Income Statement

Revenue5.74B
Revenue/Share232.17
Gross Profit2.15B
EBITDA-5.96B
Net Income-9.26B
Diluted EPS-271.16

Balance Sheet

Total Cash36.36B
Total Cash/Share1,165.18
Total Debt5.06B
Total Debt/Equity0.08
Current Ratio9.56
Book Value Per Share1,992.08

Price History

52-Week Change-19.67
52-Week High7,010
52-Week Low2,250
Moving Average 50 Days2,803.3
Moving Average 200 Days3,247.58

Statistics

Average Volume177,768
Shares Outstanding30.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate100
Trailing Annual Dividend Yield3.42
Payout Ratio0
Last Split Factor2:1
Last Split DateJanuary 10, 2019
AD